Tirzepatide / Glycine – WP Pharma Labs
US$ 21.58
oral glp-1 drugs in development What is the pipeline for future medications for obesity? Oral GLP-1: how to win
Description
Semaglutide is a peptide that belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs
Nystrm T, Gonon AT, Sjholm A, Pernow J
I believe that NLRP3 , NR3C1, Amylin, Apelin, Activin and many other targets we described in our prior publications are poised to complement the effects of GLP-1, creating comprehensive anti-aging regimens
More promising results, however, were announced the same month by Eli Lilly for its new once-daily GLP-1 pill which showed promise for weight management and for the treatment of type-2 diabetes
(US) Amgen Inc